Eko Health, Inc.
Classification
Private
About
About
Eko Health is a healthcare technology company specializing in advanced digital stethoscopes and AI-powered diagnostic software. The company aims to revolutionize cardiovascular care by integrating cutting-edge technology with traditional stethoscopes, enabling clinicians to detect heart and lung diseases more effectively and efficiently. Product/Service Line Breakdown: 1. CORE 500 Digital Stethoscope: An FDA-cleared stethoscope featuring heart disease detection AI, 3-lead ECG, and advanced audio capabilities for precise diagnostics. 2. DUO ECG + Digital Stethoscope: Combines ECG and digital stethoscope functionalities to provide comprehensive cardiac assessment tools in a single device. 3. Eko App: AI-supported analysis software that works with Eko stethoscopes to enhance the detection and monitoring of cardiovascular conditions through real-time data analysis and visualization. 4. Telehealth Solutions: Integrated telehealth platform that enables remote patient monitoring and virtual consultations, enhancing accessibility to high-quality cardiac care. 5. Eko Enterprise Platform: Provides health systems and large practices with a scalable solution for managing cardiovascular care, including analytics, reporting, and integration with existing electronic health records (EHR).
Financials
Revenue & Profit
Valuation
Ratios
People
Deals
M&A2024-03-15Completed
Investor Sponsors NorthBridge PE | Stake Tags 100% |
Deal Amount $120M | Is PE deal Yes |
Target Company Valuation $1.20 MM | Is deal PE backed Yes |
Techniques Acquisition of Assets, Taken Private | Total Acquired 100% |
Investor Sponsors
Deal Amount
$120M
Target Company Valuation
$1.20 MM
Techniques
Acquisition of Assets, Taken Private
Stake Tags
100%
Is PE deal
Yes
Is deal PE backed
Yes
Total Acquired
100%
Secondary Transaction2023-09-01Canceled
Investor Sponsors -- | Stake Tags Majority |
Deal Amount Undisclosed | Is PE deal No |
Target Company Valuation -- | Is deal PE backed Yes |
Techniques Secondary Sale, Management Buy-out (MBO) | Total Acquired 65% |
Investor Sponsors
--
Deal Amount
Undisclosed
Target Company Valuation
NaN
Techniques
Secondary Sale, Management Buy-out (MBO)
Stake Tags
Majority
Is PE deal
No
Is deal PE backed
Yes
Total Acquired
65%
Funding
Keywords
Keywords
Classified
Private